Cargando…
Cryptides Identified in Human Apolipoprotein B as New Weapons to Fight Antibiotic Resistance in Cystic Fibrosis Disease
Chronic respiratory infections are the main cause of morbidity and mortality in cystic fibrosis (CF) patients, and are characterized by the development of multidrug resistance (MDR) phenotype and biofilm formation, generally recalcitrant to treatment with conventional antibiotics. Hence, novel effec...
Autores principales: | Gaglione, Rosa, Cesaro, Angela, Dell’Olmo, Eliana, Di Girolamo, Rocco, Tartaglione, Luca, Pizzo, Elio, Arciello, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139702/ https://www.ncbi.nlm.nih.gov/pubmed/32192076 http://dx.doi.org/10.3390/ijms21062049 |
Ejemplares similares
-
Effects of human antimicrobial cryptides identified in apolipoprotein B depend on specific features of bacterial strains
por: Gaglione, Rosa, et al.
Publicado: (2019) -
Impact of a Single Point Mutation on the Antimicrobial and Fibrillogenic Properties of Cryptides from Human Apolipoprotein B
por: Gaglione, Rosa, et al.
Publicado: (2021) -
Host defence peptides identified in human apolipoprotein B as promising antifungal agents
por: Dell’Olmo, Eliana, et al.
Publicado: (2021) -
Loading of Polydimethylsiloxane with a Human ApoB-Derived Antimicrobial Peptide to Prevent Bacterial Infections
por: De Luca, Maria, et al.
Publicado: (2022) -
Novel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System
por: Cesaro, Angela, et al.
Publicado: (2022)